Page 25 - Read Online

association with poor prognosis in head and neck cancer. Head 122. Conklin KA. Chemotherapy-associated oxidative stress:
Neck 2015;37:727-34. impact on chemotherapeutic effectiveness. Integr Cancer Ther
105. Onodera Y, Motohashi H, Takagi K, Miki Y, Shibahara Y, 2004;3:294-300.
Watanabe M, Ishida T, Hirakawa H, Sasano H, Yamamoto M, 123. Sullivan LB, Chandel NS. Mitochondrial reactive oxygen
Suzuki T. NRF2 immunolocalization in human breast species and cancer. Cancer Metab 2014;2:17.
cancer patients as a prognostic factor. Endocr Relat Cancer 124. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X,
2014;21:241-52. Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM,
106. Soini Y, Eskelinen M, Juvonen P, Karja V, Haapasaari KM, Mandinova A, Schreiber SL, Lee SW. Selective killing of
Saarela A, Karihtala P. Nuclear Nrf2 expression is related to a cancer cells by a small molecule targeting the stress response
poor survival in pancreatic adenocarcinoma. Pathol Res Pract to ROS. Nature 2011;475:231-4.
2014;210:35-9. 125. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z,
107. Kawasaki Y, Ishigami S, Arigami T, Uenosono Y, Yanagita S, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J,
Uchikado Y, Kita Y, Nishizono Y, Okumura H, Nakajo A, Huang P. Selective killing of oncogenically transformed cells
Kijima Y, Maemura K, Natsugoe S. Clinicopathological through a ROS-mediated mechanism by beta-phenylethyl
signifi cance of nuclear factor (erythroid-2)-related factor isothiocyanate. Cancer Cell 2006;10:241-52.
2 (Nrf2) expression in gastric cancer. BMC Cancer 2015;15:5. 126. Sawayama H, Ishimoto T, Watanabe M, Yoshida N,
108. Yang Y, Cai X, Yang J, Sun X, Hu C, Yan Z, Xu X, Lu W, Sugihara H, Kurashige J, Hirashima K, Iwatsuki M, Baba Y,
Wang X, Cao P. Chemoprevention of dietary digitofl avone on Oki E, Morita M, Shiose Y, Baba H. Small molecule agonists
colitis-associated colon tumorigenesis through inducing Nrf2 of PPAR-gamma exert therapeutic effects in esophageal
signaling pathway and inhibition of infl ammation. Mol Cancer cancer. Cancer Res 2014;74:575-85.
2014;13:48. 127. Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P, Zheng X,
109. Kawasaki Y, Okumura H, Uchikado Y, Kita Y, Sasaki K, Sadee W, Sun D. Glucose uptake inhibitor sensitizes cancer
Owaki T, Ishigami S, Natsugoe S. Nrf2 is useful for predicting cells to daunorubicin and overcomes drug resistance in
the effect of chemoradiation therapy on esophageal squamous hypoxia. Cancer Chemother Pharmacol 2007;59:495-505.
cell carcinoma. Ann Surg Oncol 2014;21:2347-52. 128. Wu CH, Ho YS, Tsai CY, Wang YJ, Tseng H, Wei PL, Lee CH,
110. Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial Liu RS, Lin SY. In vitro and in vivo study of phloretin-induced
metabolism of reactive oxygen species. Biochemistry (Mosc) apoptosis in human liver cancer cells involving inhibition of
2005;70:200-14. type II glucose transporter. Int J Cancer 2009;124:2210-9.
111. Trachootham D, Alexandre J, Huang P. Targeting cancer cells 129. Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H,
by ROS-mediated mechanisms: a radical therapeutic approach? Colvin R, Ding J, Tong L, Wu S, Hines J, Chen X.
Nat Rev Drug Discov 2009;8:579-91. A small-molecule inhibitor of glucose transporter 1
112. Klaunig JE, Kamendulis LM. The role of oxidative stress in downregulates glycolysis, induces cell-cycle arrest, and
carcinogenesis. Annu Rev Pharmacol Toxicol 2004;44:239-67. inhibits cancer cell growth in vitro and in vivo. Mol Cancer
113. Sullivan R, Graham CH. Chemosensitization of cancer by Ther 2012;11:1672-82.
nitric oxide. Curr Pharm Des 2008;14:1113-23. 130. Ganapathy-Kanniappan S, Vali M, Kunjithapatham R,
114. Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Buijs M, Syed LH, Rao PP, Ota S, Kwak BK, Loffroy R,
Becker K, Yates JR 3rd, Felding-Habermann B. Adaptation Geschwind JF. 3-bromopyruvate: a new targeted antiglycolytic
of energy metabolism in breast cancer brain metastases. agent and a promise for cancer therapy. Curr Pharm
Cancer Res 2007;67:1472-86. Biotechnol 2010;11:510-7.
115. Young TW, Mei FC, Yang G, Thompson-Lanza JA, Liu J, 131. Zhou Y, Tozzi F, Chen J, Fan F, Xia L, Wang J, Gao G,
Cheng X. Activation of antioxidant pathways in ras-mediated Zhang A, Xia X, Brasher H, Widger W, Ellis LM,
oncogenic transformation of human surface ovarian epithelial Weihua Z. Intracellular ATP levels are a pivotal determinant
cells revealed by functional proteomics and mass spectrometry. of chemoresistance in colon cancer cells. Cancer Res
Cancer Res 2004;64:4577-84. 2012;72:304-14.
116. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH. 132. Yu SJ, Yoon JH, Yang JI, Cho EJ, Kwak MS, Jang ES, Lee JH,
Reactive oxygen species regulate angiogenesis and tumor Kim YJ, Lee HS, Kim CY. Enhancement of hexokinase II
growth through vascular endothelial growth factor. Cancer Res inhibitor-induced apoptosis in hepatocellular carcinoma
2007;67:10823-30. cells via augmenting ER stress and anti-angiogenesis by
117. Kondoh H, Lleonart ME, Bernard D, Gil J. Protection from protein disulfi de isomerase inhibition. J Bioenerg Biomembr
oxidative stress by enhanced glycolysis; a possible mechanism 2012;44:101-15.
of cellular immortalization. Histol Histopathol 2007;22:85-90. 133. Tong J, Xie G, He J, Li J, Pan F, Liang H. Synergistic
118. Pervaiz S, Clement MV. Tumor intracellular redox status and antitumor effect of dichloroacetate in combination with
drug resistance-Serendipity or a causal relationship? Curr 5-fl uorouracil in colorectal cancer. J Biomed Biotechnol
Pharm Des 2004;10:1969-77. 2011;2011:740564.
119. Tiligada E. Chemotherapy: induction of stress responses. 134. Shen YC, Ou DL, Hsu C, Lin KL, Chang CY, Lin CY, Liu SH,
Endocr Relat Cancer 2006;13 Suppl 1:S115-24. Cheng AL. Activating oxidative phosphorylation by a pyruvate
120. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, dehydrogenase kinase inhibitor overcomes sorafenib resistance
Murphy MP, Kelso GF, Smith RA, Kinzler KW, of hepatocellular carcinoma. Br J Cancer 2013;108:72-81.
Vogelstein B. Ferredoxin reductase affects p53-dependent, 135. Miskimins WK, Ahn HJ, Kim JY, Ryu S, Jung YS, Choi JY.
5-fluorouracil-induced apoptosis in colorectal cancer cells. Synergistic anti-cancer effect of phenformin and oxamate.
Nat Med 2001;7:1111-7. PLoS One 2014;9:e85576.
121. Hwang IT, Chung YM, Kim JJ, Chung JS, Kim BS, Kim HJ, 136. Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D, Lee YM,
Kim JS, Yoo YD. Drug resistance to 5-FU linked to reactive Ku SK, Jung Y, Kwak MK. NRF2 blockade suppresses colon
oxygen species modulator 1. Biochem Biophys Res Commun tumor angiogenesis by inhibiting hypoxia-induced activation
2007;359:304-10. of HIF-1alpha. Cancer Res 2011;71:2260-75.

Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦ 181